>>14492717
Pfizer, the FDA, and Bribes Aplenty
On December 28, 2019, just as news of the Wuhan plague sank its teeth into American society, Pfizer CEO Albert Bourla confronted then-FDA director Stephen Hahn with what he described as an intractable dilemma: Bourla lamented Pfizer’s “revenue loss,” a curious choice of words to describe a pharmaceutical manufacturer that netted $16.7 billion in 2019, the CEO of which earned $17mn in 2019 and $22mn in 2020–after the company’s Covid-19 vaccine hit the shelves. Those figures exclude the tens of millions of dollars Bourla gets from benefits, per diems and stock options, assets which, if added to his yearly salary, place him among the highest paid CEOs in the world.
Hahn, Bourla, and a gaggle of FDA and Pfizer officials held private talks to discuss Pfizer’s self-perceived financial woes. The meeting did not take place at Pfizer’s corporate headquarters in Manhattan. Nor did the conference happen at the FDA’s mammoth complex in Silver Springs, Maryland. This was unusual because official talks between the FDA and big pharma typically occur at one of those two locations, not a boardroom suite at the Hay-Adams Hotel in Washington, D.C.
Bourla had requested a clandestine gathering, having told Hahn that trade secrets would be analyzed and that Pfizer’s codified agreement with the FDA stipulated that Pfizer had authority to request covert discussions to prevent public dissemination of confidential information. The FDA’s acceptance of those terms shows that it and big pharma share a matrimonial bedchamber.
He claimed to have “come into possession” of the Genome sequence for a highly transmissible respiratory infection that was ravaging Wuhan China and would undoubtedly infect America. In describing the virus, Bourla said, “It appears to be no more lethal than seasonal influenza. It seems to be airborne and spreads rapidly among infected populations. The symptoms may appear perilous, but based on our analysis, the average person has a 99.6% chance of full recovery.”
Bourla put forward an agenda: If the FDA approved Pfizer’s vaccine, which was already in the works, Pfizer would kick back 15% of profit over the next 36 months. “You can use that money to disperse research grants or for whatever you want,” Bourla told Hahn. “Truth be told, we probably don’t need a vaccine for this, but it’s important that you impress upon your peers, the CDC and people like Anthony Fauci, that a vaccine is necessary to ensure survival of the American people. The Trump administration must be made to believe this. The quicker we get this rolling, the faster we can distribute the vaccine, and people will feel safe.”
Bourla proposed a five-year vaccination plan, to include booster shots, to maximize profit. If society began to feel safe, a variation of the virus could be invented to frighten naïve people into demanding reformulated vaccinations, Bourla said.
In response, Hahn made a startling confession: one of Pfizer’s competitors had already pitched a similar plan to the FDA. Without naming the competitor, Hahn said emergency use authorization would have to be shared among “reputable” vaccine manufacturers, that “there would be a big enough slice of pie for everyone to enjoy.”
https://realrawnews.com/2021/08/pfizer-the-fda-and-bribes-aplenty/
yeah yeah, it's RRN, but if anons get off their sanctimonious high horse and READ the full article, there's plenty of leads to dig on…